What is the European Antibody Congress?

 

European Antibody Congress

 

  • Develop your production by learning about innovative new platforms and technologies
     
  • Hear industry leader’s views on the clinical and commercial future of antibodies and how this might affect your business. 
     
  • Learn about the latest discoveries and developments in the production of new antibody drugs.  
     
  • Network with the real pioneers, thought leaders and influencers

"Excellent new research in the area of Antibody Engineering. Very innovative. Excellent list of speakers. Beautifully organized meeting."
Eugene Zhukovsky, Affimed Gmbh

 

Download the prospectus

 

Where mAb, ADC and next gen technology stakeholders meet

Why get involved?

Do you need to meet mAb, ADC, multi format and next generation technology decision makers, influencers and end users?

If so we have a room full from large and mid cap pharma, large and SME biotech, academic and research institutes, government bodies and regulatory boards. 

Why sponsor?

  • Speak to a room full of Antibody experts
  • Host a roundtable and meet your customers
  • Take advantage of 1-2-1 partnering
  • Let us generate sales leads pre-event
  • Hundreds of private meetings arranged

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Brand new Platform Technology stream
  • Generate new sales leads
  • Raise brand profile

Get the sponsorship prospectus

50 new technologies on display

 

  • Event Partner

    Canton of Basel-Stadt at European Antibody Congress
  • Gold Sponsor

    Catalent at European Antibody Congress
  • Gold Sponsor

    NDA Group at European Antibody Congress
  • Gold Sponsor

    ForteBio at European Antibody Congress
  • Gold Sponsor

    Fujifilm Diosynth Biotechnologies at European Antibody Congress
  • Gold Sponsor

    KBI Biopharma, Inc. at European Antibody Congress
  • Associate Sponsor

    Abzena at European Antibody Congress
  • Associate Sponsor

    Asterand U.K. at European Antibody Congress
  • Associate Sponsor

    Clean Cells at European Antibody Congress
  • Exhibitor

    Myoderm at European Antibody Congress
  • Exhibitor

    Aldevron Llc at European Antibody Congress
  • Exhibitor

    Agilent Technologies at European Antibody Congress
  • Exhibitor

    Horiba at European Antibody Congress

Join them

 

Interactive Sessions Offer High Level Networking

 

European Antibody Congress

"Highly focussed meeting with most participants being open to sharing experiences and data"
Steve Megit, Immunocore Ltd

European Antibody Congress

"Very good opportunity to meet new and existing contacts"
Tatyana Hrechdakian, Quality Assistance

European Antibody Congress

"The best global antibody meeting"
Alain Beck, Centre d’Immunologie Pierre Fabre

 

Co-located with

 

  World Biosimilar Congress

  HPAPI World Congress

 

Be part of the conversation

 

PRA - Clinical Trial Liaison

Download White Paper : Engaging Clinical Trial Sites – The Role of the Clinical Trial Liaison

Enrollment in clinical trials is heavily dependent on two very important customers: the research subject and the clinical trial investigator. Research subjects are highly valuable ...

The post Download White Paper : Engaging Clinical Trial Sites – The Role of the Clinical Trial Liaison appeared first on Total Biopharma.

benefit risk, quantification, pharma, Drug Safety

Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company.

At the 2014 World Drug Safety Congress Americas Susan Duke, GSK, gave a presentation on “Implementing benefit-risk thinking and quantification into the culture and processes ...

The post Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company. appeared first on Total Biopharma.

diabetes, cognition, world drug safety congress americas, cambridge cognition

Whitepaper: Diabetes and Cognition

Disorder-specific impairments and treatment-induced effects on cognitive function Diabetes mellitus is defined by high blood glucose concentrations and the body’s inability to regulate these concentrations ...

The post Whitepaper: Diabetes and Cognition appeared first on Total Biopharma.

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter